Taiwan's Optimer Biotech Part Of Bribe Probe By U.S. Parent Company
This article was originally published in PharmAsia News
Executive Summary
U.S.-based Optimer Pharmaceuticals may have offered bribes in the form of shares of its Optimer Biotechnology subsidiary in Taiwan to Optimer's co-founder and former chairman who stepped down last week.